期刊文献+

表达犬细小病毒VP2蛋白的嵌合狂犬病病毒生物学特性的研究 被引量:3

Biological Characteristics of a Chimeric Rabies Virus Expressing Canine Parvovirus VP2 Protein
原文传递
导出
摘要 为获得狂犬病病毒和犬细小病毒的二联疫苗,本研究运用分子生物学技术在狂犬病病毒基因组的G基因与L基因之间插入犬细小病毒VP2基因,通过反向遗传操作系统拯救获得了含犬细小病毒VP2基因的嵌合狂犬病病毒HEP-Flury(VP2),并研究了该病毒的生物学特性。结果表明,嵌合狂犬病病毒HEP-Flury(VP2)可以在BHK-21细胞上稳定繁殖,在传代10次后,外源基因VP2能高效表达;以HEP-Flury(VP2)免疫小鼠,可以诱导免疫小鼠产生抗狂犬病病毒和抗犬细小病毒的抗体。 To obtain a bivalence vaccine against canine rabies virus and canine parvovirus, a chimeric rabies virus expressing canine parvovirus VP2 protein was generated by the technique of reverse genetics. It was shown that the chimeric virus designated as HEP-Flury(VP2) grew well on BHK-21 cells and the VP2 gene could still be stably expressed after ten passages on BHK-21 cells. Experiments on the mice immunized with the chimeric virus HEP-Flury(VP2) demonstrated that specific antibodies against rabies virus and canine parvovirus were induced in immunized mice after vaccination with the live chimeric virus.
出处 《病毒学报》 CAS CSCD 北大核心 2009年第5期362-367,共6页 Chinese Journal of Virology
基金 国家"863"项目(2006AA10A204)
关键词 狂犬病病毒 反向遗传 犬细小病毒 疫苗 rabies virus reverse genetics canine parvovirus vaccine
  • 相关文献

参考文献17

  • 1Conzelmann K K, Cox J H, Schneider L G, et al. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19 [J]. Virology, 1990, 175(2) : 485-499.
  • 2艾军,金晓芹,孙京臣,罗琴芳,黄文科,郭霄峰.禽流感病毒HA基因在狂犬病毒中的表达[J].华南农业大学学报,2008,29(1):81-83. 被引量:5
  • 3刘晓慧,艾军,郭霄峰,孙京臣,梁红茹.表达绿色荧光蛋白嵌合狂犬病病毒HEP-GFP株的拯救[J].病毒学报,2008,24(5):401-403. 被引量:9
  • 4Schnell M J, Mebatsion T, Conzelmann K K. Infectious rabies viruses from cloned cDNA[J].EMBO J, 1994, 13 (18) : 4195-4203.
  • 5McGettigan J P, Foley H D, Belyakov I M, et al. Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates [J]. J Virol, 2001, 75(9): 4430-4434.
  • 6McGettigan J P, Sarma S, Orenstein, et al. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector[J].J Virol, 2001, 75(18) : 8724-8732.
  • 7Siler C A, McGettigan J P, Dietzschold B, et al. Live and killed rhabdovirus-based vectors as potential hepatitis Cvaccines[J].Virology, 2002, 292(1): 24-34.
  • 8Smith M E, Koser M, Xiao S, et al. Rabies virus glycoprotein as a carrier for anthrax protective antigen[J]. Virology, 2006, 353(2): 344-56.
  • 9Faber M, Lamirande M L, Papaneri A, et al. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS- CoV) S protein results in the production of high levels of SARS-CoV- neutralizing antibodies [J]. J Gen Virol, 2005, 86(Pt 5) :1435-1440.
  • 10Wu X, Rupprecht C E. Glycoprotein gene relocation in rabies virus[J]. VirusRes, 2008, 131(1): 95-99.

二级参考文献37

  • 1罗明,张茂林,涂长春.我国狂犬病流行状况分析及防治对策[J].中国人兽共患病杂志,2005,21(2):188-190. 被引量:137
  • 2郭霄峰,富振芳.狂犬病毒糖蛋白基因的重排及病毒的拯救[J].华南农业大学学报,2006,27(1):104-106. 被引量:24
  • 3艾军,林宝珍,郭霄峰.从克隆的cDNA拯救狂犬病毒HEP-Flury株[J].动物医学进展,2006,27(2):99-100. 被引量:11
  • 4CONZELMANN K K, COX J H, SCHNEIDER L G, et al. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19 [ J ]. Virology, 1990,175:485-499.
  • 5MEBATSION T, WEILAND F, CONZELMANN K K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with transmembrane spike glycoprotein[J]. J Virol, 1999,73:242-250.
  • 6SCHNELL M J, MEBATSION T, CONZELMANN K K.Infectious rabies viruses from cloned cDNA.[ J ]. EMBO J, 1994,13:4 195-4 203.
  • 7LAWSON N D, STILLMAN E A, WHITT M A. Recombinant vesicular stomatitis viruses from DNA [ J ]. Proc Natl Acad Sci USA, 1995, 92:4 477-4 481.
  • 8COLLINS P L, HILL M G, CAMARGO E. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5'proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development[ ] ]. Proc Natl Acad Sci USA, 1995,92:11 563-11 567.
  • 9KATO A, SAKAI Y, SHIODA T. Initiation of sendai virus multiplication from transfected cDNA or RNA with negative or positive sense [ J ]. Genes Cells, 1996, 1 : 569-579.
  • 10WERTZ G W, PEREPELITSA V P, BALL L A. Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA vires [ J ]. Proc Nail Acad Sci USA, 1998, 95:3 501-3 506.

共引文献29

同被引文献26

  • 1郭霄峰,富振芳.狂犬病毒糖蛋白基因的重排及病毒的拯救[J].华南农业大学学报,2006,27(1):104-106. 被引量:24
  • 2邱薇,范泉水,李作生,杨美峰,郑颖,李丽红,王双印,李江,夏咸柱.犬细小病毒核酸疫苗制备及免疫试验[J].动物医学进展,2006,27(3):78-81. 被引量:8
  • 3向菁,王红宁,鲜凌瑾,张夏兰,周庆哲.“自杀性”DNA疫苗研究进展[J].动物医学进展,2007,28(5):83-87. 被引量:6
  • 4REED A P,JONES E V,MILLER T J,et al.Nucleotide se-quence and genome organization of canine parvovirus[J].JVirol,1988,62(1):266-276.
  • 5DOKI M,FUJITA K,MIURA R,et al.Sequence analysis ofVP2gene of canine parvovirus isolated from domestic dogs inJapan in 1999and 2000[J].Comp Immunol Microbiol InfectDis,2006,29(4):199-206.
  • 6CHOI H Y,JUN M H,PARK S K.Virological studies on thepuppies experimentally infected with canine parvovirus[J].JVet Res,1991,31(3):303-309.
  • 7PARRISH C R,AQUADRO C F,STRASSHEIM M L,et al.Rapid antigenic-type replacement and DNA sequence evolutionof canine parvovirus[J].J Virol,1991,65(12):6544-6552.
  • 8BATTILANI M,CIULLI S,TISATO E,et al.Genetic analysisof canine parvovirus isolates(CPV-2)from dogs in Italy[J].Virus Res,2002,83(2):149-157.
  • 9IAN J A,MARK K S.Wanted,dead or alive:new viral vaccines[J].Antiviral Res,2009,84(2):119-130.
  • 10KANDUC D.“Self-Nonself”peptides in the design of vaccines[J].Curr Pharm Des,2009,15(28):3283-3289.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部